LBA11 Neoadjuvant toripalimab plus lenvatinib and GEMOX in resectable, high-risk intrahepatic cholangiocarcinoma: A randomized, multicenter, open-label phase II-III clinical trialGuobang Shi, Jian Zou, Jian Zhou et al.|Annals of Oncology|2025Cited by 2